Doxorubicin‐induced cardiomyopathy treated with carvedilol

Publisher Website
Google Scholar
Abstract
Even today, heart failure due to doxorubicin‐induced dilated cardiomyopathy seems to have a poor prognosis, as it is often irreversible and relatively unresponsive to standard medical treatment. This paper describes the first case of a patient complaining of severe symptoms of congestive heart failure due to doxorubicin‐induced dilated cardiomyopathy unresponsive to standard medical treatment (digoxin, diuretics, and angiotensin‐converting enzyme inhibitor), who showed complete clinical recovery and significant improvement of left ventricular dysfunction after carvedilol treatment. It also illustrates the possibility that carvedilol may be a first‐choice drug for the treatment of this disease.